Detecting prion protein gene mutations by denaturing gradient gel electrophoresis

John K. Fink, Michael L. Peacock, James T. Warren, Allen D. Roses, Stanley B. Prusiner

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Mutations of the prion protein (PrP) gene are present in patients with Gerstmann–Sträussler–Scheinker syndrome (GSS), familial Creutzfeldt–Jakob disease (CJD), and fatal familial insomnia (FF1). We developed a denaturing gradient gel electrophoresis (DGGE) strategy that readily identifies point mutations in the PrP coding sequence. By comparison with appropriate controls, haplotypes often may be deduced. This method permits samples from many patients with GSS, CJD, as well as patients with unusual degenerative neurologic disorders, to be screened rapidly, sensitively, and inexpensively for the presence of known and novel PrP mutations. We illustrate the sensitivity of this approach by reporting 2 novel polymorphisms in the PrP coding sequence. © 1994 Wiley‐Liss, Inc.

Original languageEnglish (US)
Pages (from-to)42-50
Number of pages9
JournalHuman mutation
Volume4
Issue number1
DOIs
StatePublished - 1994

Fingerprint

Denaturing Gradient Gel Electrophoresis
Mutation
Genes
Fatal Familial Insomnia
Point Mutation
Neurodegenerative Diseases
Haplotypes
Prion Proteins

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

Fink, John K. ; Peacock, Michael L. ; Warren, James T. ; Roses, Allen D. ; Prusiner, Stanley B. / Detecting prion protein gene mutations by denaturing gradient gel electrophoresis. In: Human mutation. 1994 ; Vol. 4, No. 1. pp. 42-50.
@article{c0b4686b587f4ce29eae8efb4b1e1651,
title = "Detecting prion protein gene mutations by denaturing gradient gel electrophoresis",
abstract = "Mutations of the prion protein (PrP) gene are present in patients with Gerstmann–Str{\"a}ussler–Scheinker syndrome (GSS), familial Creutzfeldt–Jakob disease (CJD), and fatal familial insomnia (FF1). We developed a denaturing gradient gel electrophoresis (DGGE) strategy that readily identifies point mutations in the PrP coding sequence. By comparison with appropriate controls, haplotypes often may be deduced. This method permits samples from many patients with GSS, CJD, as well as patients with unusual degenerative neurologic disorders, to be screened rapidly, sensitively, and inexpensively for the presence of known and novel PrP mutations. We illustrate the sensitivity of this approach by reporting 2 novel polymorphisms in the PrP coding sequence. {\circledC} 1994 Wiley‐Liss, Inc.",
author = "Fink, {John K.} and Peacock, {Michael L.} and Warren, {James T.} and Roses, {Allen D.} and Prusiner, {Stanley B.}",
year = "1994",
doi = "10.1002/humu.1380040106",
language = "English (US)",
volume = "4",
pages = "42--50",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "1",

}

Detecting prion protein gene mutations by denaturing gradient gel electrophoresis. / Fink, John K.; Peacock, Michael L.; Warren, James T.; Roses, Allen D.; Prusiner, Stanley B.

In: Human mutation, Vol. 4, No. 1, 1994, p. 42-50.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Detecting prion protein gene mutations by denaturing gradient gel electrophoresis

AU - Fink, John K.

AU - Peacock, Michael L.

AU - Warren, James T.

AU - Roses, Allen D.

AU - Prusiner, Stanley B.

PY - 1994

Y1 - 1994

N2 - Mutations of the prion protein (PrP) gene are present in patients with Gerstmann–Sträussler–Scheinker syndrome (GSS), familial Creutzfeldt–Jakob disease (CJD), and fatal familial insomnia (FF1). We developed a denaturing gradient gel electrophoresis (DGGE) strategy that readily identifies point mutations in the PrP coding sequence. By comparison with appropriate controls, haplotypes often may be deduced. This method permits samples from many patients with GSS, CJD, as well as patients with unusual degenerative neurologic disorders, to be screened rapidly, sensitively, and inexpensively for the presence of known and novel PrP mutations. We illustrate the sensitivity of this approach by reporting 2 novel polymorphisms in the PrP coding sequence. © 1994 Wiley‐Liss, Inc.

AB - Mutations of the prion protein (PrP) gene are present in patients with Gerstmann–Sträussler–Scheinker syndrome (GSS), familial Creutzfeldt–Jakob disease (CJD), and fatal familial insomnia (FF1). We developed a denaturing gradient gel electrophoresis (DGGE) strategy that readily identifies point mutations in the PrP coding sequence. By comparison with appropriate controls, haplotypes often may be deduced. This method permits samples from many patients with GSS, CJD, as well as patients with unusual degenerative neurologic disorders, to be screened rapidly, sensitively, and inexpensively for the presence of known and novel PrP mutations. We illustrate the sensitivity of this approach by reporting 2 novel polymorphisms in the PrP coding sequence. © 1994 Wiley‐Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0028287867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028287867&partnerID=8YFLogxK

U2 - 10.1002/humu.1380040106

DO - 10.1002/humu.1380040106

M3 - Article

C2 - 7951257

AN - SCOPUS:0028287867

VL - 4

SP - 42

EP - 50

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 1

ER -